​APHL collaborates with CDC to assure the proficiency of newborn screening laboratory testing. The association works in partnership with the CDC’s Newborn Screening Molecular Biology Branch to support the Newborn Screening Quality Assurance Program (NSQAP).

NSQAP is a voluntary, non-regulatory program to maintain and enhance the quality of newborn test results at state public health laboratories. It provides services to more than 85 US newborn screening laboratories, 31 manufacturers of diagnostic products and laboratories in 67 countries. NSQAP has served as the reputable source for newborn screening quality assurance services for over 33 years.

NSQAP sends coded specimens to participating laboratories to assess their testing proficiency. If a laboratory makes an error in identification, NSQAP works with the institution to identify the error and improve laboratory practices. The program also publishes quarterly reports to allow laboratories to benchmark practices against their peers.

Newborn Screening Analyte Interference List

The Newborn Screening Analyte Interference List is a compilation of published and observed analyte interferences of newborn screening assays. The list serves as a central, one-stop resource for all known newborn screening assay interferences. Users can both review and add interferences to the list. Categories include:

How to Nominate an Interference

To nominate an interference, please review the example and/or the reported analyte interferences above.

  • Select " Nominate an Interference"
  • Enter your data. Note that some fields are mandatory. Important: You must enter all your data at one time. It is not possible to save your data and return to it later. Locate your information prior to starting the entry.
  • Select Submit to send analyte interference to the QA/QC subcommittee for review.